Personal tools
You are here: Home Science & Technology Cardiovascular diseases
Document Actions

Cardiovascular diseases

The number of people suffering from cardiovascular disease is vast. The number of knowledge workers active in this field in the Amsterdam Area is too.

Cardiovascular diseases are often the result of multiple different factors, and therefore demand a multidisciplinary research orientation. As with cancer and neurosciences, this requires strong interactions between pre-clinical and clinical researchers, to optimise translation to the clinic. It also requires links between programmes on metabolic disorders that cause vascular dysfunction (such as diabetes and lipid disorders and obesity), and programmes on thrombosis and atherosclerosis. Innovative cardiovascular imaging platforms support these programmes.
In addition, there is a strong focus on epidemiological studies to fine-tune prevention programmes, and extensive databases derived from family studies have been built up to obtain in-depth knowledge of the inheritability of cardiovascular diseases. This knowledge is directly translated into innovative therapeutics and diagnostics.

Main therapy targets:

  • Thrombosis
  • Atherosclerosis
  • Lipid disorders

Main therapies and tools:

  • Advanced Imaging Technology
  • Cholesterol-lowering drug discovery
  • Anticoagulants
  • Gene therapy
  • Patient cohorts
clmn_image

It’s business stupid

What is it with the Dutch that they have such difficulty grabbing business opportunities in a changing world? We have the brains, we have the money and the opportunities are plenty. Still, during the last 40 years hardly any company of substantial size has emerged next to the old industry in the AEX.  Oil, food, materials and financial services dominate the landscape.

We have left the environmental challenges to environmentalists, rather then building innovative businesses in solar or wind energy to help face them. We have exported our knowledge on agriculture around the world, and now that we can more intelligently engineer crops we let the opportunity pass due to invalid arguments around GMOs. Now that  “kweekersrecht” is being substituted by patent law we complain instead of adapt.

Continue

 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: